Literature DB >> 31261270

The Impact of Body Mass Index (BMI) on 30-day Outcomes Following Posterior Spinal Fusion in Neuromuscular Scoliosis.

Azeem Tariq Malik1, Robert Tamer, Elizabeth Yu, Jeffery Kim, Safdar N Khan.   

Abstract

STUDY
DESIGN: Retrospective.
OBJECTIVE: Assess the impact of varying severity of BMI on 30-day outcomes following posterior spinal fusions in neuromuscular scoliosis. SUMMARY OF BACKGROUND DATA: Obesity in the pediatric population is shown to be associated with adverse outcomes across varying specialties. The weight-outcome relationship in neuromuscular scoliosis has not been thoroughly investigated.
METHODS: The 2012-2016 American College of Surgeons - National Surgical Quality Improvement (ACS-NSQIP) database was queried using Current Procedural Terminology codes 22800, 22802, and 22804 to identify patients undergoing posterior spinal fusion for neuromuscular scoliosis only. BMI was classified into four groups based on the Center for Disease Control (CDC) BMI-for-age percentile chart - Normal weight (BMI ≥5th to <85th percentile), Underweight (<5th percentile), Overweight (≥85th to <95th percentile) and Obese (≥95th percentile). Multivariate regression models were built to understand the impact of varying BMI severity classes on 30-day outcomes.
RESULTS: A total of 1291 patients underwent posterior spinal fusion for neuromuscular scoliosis. A total of 695 (53.8%) were normal weight, 286 (22.2%) were underweight, 145 (11.2%) were overweight, and 165 (12.8%) were obese. Obese patients versus normal weight patients were at a significantly higher risk of surgical site infections (OR 2.15; P = 0.035), wound dehiscence (OR 1.58; P = 0.037), urinary tract infections (OR 3.41; P = 0.010), and 30-day readmissions (OR 1.94; P = 0.029). Of note, overweight versus normal weight individuals had higher odds of cardiopulmonary complications (OR 8.82; P = 0.024). No significant associations were seen for varying BMI and other 30-day outcomes.
CONCLUSIONS: Obese neuromuscular patients undergoing PSF have higher odds of experiencing adverse outcomes, particularly surgical site infections, urinary tract infections, and readmissions. Providers should promote prevention strategies, such as dietary modification and/or early physical activity in these high-risk patients to minimize the risks of experiencing complications in the acute postoperative period. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2019        PMID: 31261270     DOI: 10.1097/BRS.0000000000003084

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  4 in total

1.  Evaluating the association between pulmonary abnormalities and complications following pediatric hip dysplasia surgery.

Authors:  Jordan Pizzarro; Theodore Quan; Joseph E Manzi; Frank R Chen; Alex Gu; Sean Tabaie
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-05-09

2.  Clinical Issues in Indication, Correction, and Outcomes of the Surgery for Neuromuscular Scoliosis: Narrative Review in Pedicle Screw Era.

Authors:  Hak Sun Kim; Ji Won Kwon; Kun-Bo Park
Journal:  Neurospine       Date:  2022-01-29

3.  Prevention of Surgical Site Infections in Neonates and Children: Non-Pharmacological Measures of Prevention.

Authors:  Aniello Meoli; Lorenzo Ciavola; Sofia Rahman; Marco Masetti; Tommaso Toschetti; Riccardo Morini; Giulia Dal Canto; Cinzia Auriti; Caterina Caminiti; Elio Castagnola; Giorgio Conti; Daniele Donà; Luisa Galli; Stefania La Grutta; Laura Lancella; Mario Lima; Andrea Lo Vecchio; Gloria Pelizzo; Nicola Petrosillo; Alessandro Simonini; Elisabetta Venturini; Fabio Caramelli; Gaetano Domenico Gargiulo; Enrico Sesenna; Rossella Sgarzani; Claudio Vicini; Mino Zucchelli; Fabio Mosca; Annamaria Staiano; Nicola Principi; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-06-27

4.  The Relationship between Obesity and Clinical Outcomes in Young People with Duchenne Muscular Dystrophy.

Authors:  Natassja Billich; Justine Adams; Kate Carroll; Helen Truby; Maureen Evans; Monique M Ryan; Zoe E Davidson
Journal:  Nutrients       Date:  2022-08-12       Impact factor: 6.706

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.